Subscribe
Subscribe & Save!
Subscribe now and save 50% off the cover price of the Indianapolis Monthly magazine.
×

Alzheimer’s

default featured image
Read More

The Unblinding: Has Lilly Solved the Alzheimer’s Puzzle? — An Epilogue

The search continues.

Read More

The Unblinding: Has Lilly Solved The Alzheimer’s Puzzle?

Eli Lilly and Company has spent three decades and $3 billion in an Ahab-like quest to develop the world’s first effective drug to treat Alzheimer’s disease.

default featured image
Read More

Top Doctors Q&A: Malaz A. Boustani

“Personally, I don’t take any of these medications or recommend them to my family members.”

default featured image
Read More

Life after Zyprexa: the Future of Eli Lilly and Company

“We want high quality of life as long as possible, don’t we?” says Lilly executive Jan Lundberg. “Many of our current diseases are chronic, and they accumulate with age, so there are major demands coming from the aging population.”

X
X